ACE2 and COVID-19: The reason why individuals with cardiovascular diseases are more likely to have COVID-19-related cardiac sequelae is that the content and activity of angiotensin-converting enzyme 2 (ACE2), the key receptor of SARS-CoV-2, in cardiomyocytes are greater in individuals with cardiovascular diseases than in healthy individuals30).